{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:08:51Z","timestamp":1790190531411,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20181147"],"award-info":[{"award-number":["BK20181147"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BE2019640"],"award-info":[{"award-number":["BE2019640"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jpba.2024.116655","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T12:16:52Z","timestamp":1735820212000},"page":"116655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and validation of an UPLC-MS\/MS method with polarity switching for simultaneous determination of 14 antiepileptic drugs and 2 metabolites in human serum"],"prefix":"10.1016","volume":"255","author":[{"given":"Xiao-han","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-feng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-quan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpba.2024.116655_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1474-4422(21)00096-X","article-title":"Epilepsy care in China and its relevance for other countries","volume":"20","author":"Cendes","year":"2021","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jpba.2024.116655_bib2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1474-4422(21)00023-5","article-title":"Epilepsy in China: major progress in the past two decades","volume":"20","author":"Ding","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpba.2024.116655_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pharmthera.2019.05.010","article-title":"An update for epilepsy research and antiepileptic drug development: toward precise circuit therapy","volume":"201","author":"Wang","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jpba.2024.116655_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61393-9","article-title":"Antiseizure adverse drug reaction and associated factors among epileptic patients at Jimma Medical Center: a prospective observational study","volume":"14","author":"Bayane","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2024.116655_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109566","article-title":"Predictors and associated factors with adverse drug reaction in people with epilepsy","volume":"150","author":"Ogunjimi","year":"2024","journal-title":"Epilepsy Behav."},{"issue":"3","key":"10.1016\/j.jpba.2024.116655_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17425255.2020.1724956","article-title":"Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects","volume":"16","author":"Johannessen Landmark","year":"2020","journal-title":"Expert Opin. Drug Met."},{"issue":"1-02","key":"10.1016\/j.jpba.2024.116655_bib7","first-page":"9","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"10.1016\/j.jpba.2024.116655_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FTD.0000000000000546","article-title":"Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update","volume":"40","author":"Patsalos","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.jpba.2024.116655_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/17425255.2024.2362190","article-title":"Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medications","volume":"20","author":"D'Onofrio","year":"2024","journal-title":"Expert Opin. Drug Met."},{"issue":"1","key":"10.1016\/j.jpba.2024.116655_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bcp.13400","article-title":"Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and children","volume":"84","author":"van Dijkman","year":"2018","journal-title":"Br. J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.jpba.2024.116655_bib11","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/epi.16364","article-title":"Pharmacokinetic interaction between modified Atkins diet and antiepileptic drugs in adults with drug-resistant epilepsy","volume":"60","author":"Kverneland","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpba.2024.116655_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2013.05.026","article-title":"Cross-reactivities and structure-reactivity relationships of six benzodiazepines to EMIT(\u00ae) immunoassay","volume":"84","author":"Bertol","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jpba.2024.116655_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202200622","article-title":"A simple and easy non-derivatization gas chromatography-mass spectrometry method for simultaneous quantification of valproic acid, gabapentin, pregabalin, and vigabatrin in human plasma","volume":"46","author":"Jin","year":"2023","journal-title":"J. Sep. Sci."},{"issue":"13","key":"10.1016\/j.jpba.2024.116655_bib14","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/jssc.202200246","article-title":"Development and evaluation of a simple and easy high-performance liquid chromatography-ultraviolet system simultaneously suitable for determination of 24 anti-epileptic drugs in plasma","volume":"45","author":"Zhao","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2024.116655_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116099","article-title":"Simultaneous monitoring of seven antiepileptic drugs by dried blood spot and dried plasma spot sampling: method validation and clinical application of a LC-MS\/MS-based technique","volume":"243","author":"Cao","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.jpba.2024.116655_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jms.4369","article-title":"A fast and simple approach for the quantification of 40 illicit drugs, medicines, and pesticides in blood and urine samples by UHPLC-MS\/MS","volume":"54","author":"Franco de Oliveira","year":"2019","journal-title":"J. Mass Spectrom."},{"issue":"12","key":"10.1016\/j.jpba.2024.116655_bib17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/bmc.2726","article-title":"Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring","volume":"26","author":"Shibata","year":"2012","journal-title":"Biomed. Chromatogr."},{"issue":"7","key":"10.1016\/j.jpba.2024.116655_bib18","first-page":"948","article-title":"Determination of eleven antiepileptic drugs in human plasma by UPLC-MS\/MS","volume":"52","author":"Wang","year":"2021","journal-title":"Chin. J. Pharm."},{"issue":"8","key":"10.1016\/j.jpba.2024.116655_bib19","first-page":"900","article-title":"Simultaneous determination of twelve antiepileptic drugs in serum by ultra high performance liquid chromatography-tandem mass spectrometry","volume":"38","author":"Dai","year":"2020","journal-title":"Chin. J. Chromatogr."},{"key":"10.1016\/j.jpba.2024.116655_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114615","article-title":"Monitoring alcohol-use-disorder medication compliance by LC-MS\/MS determination of urinary ethyl glucuronide, acamprosate, naltrexone, and 6\u03b2-naltrexol using zirconia-based hybrid solid-phase extraction","volume":"212","author":"Kim","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116655_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpba.2014.12.004","article-title":"Simultaneous quantitative determination of celecoxib and its two metabolites using liquid chromatography-tandem mass spectrometry in alternating polarity switching mode","volume":"107","author":"Oh","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116655_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112790","article-title":"Challenges in simultaneous extraction and chromatographic separation of metformin and three SGLT-2 inhibitors in human plasma using LC-MS\/MS","volume":"175","author":"Shah","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116655_bib23","unstructured":"US Department of Health and Human Services, Food and Drug Administration, Guidance for Industry (2018), Bioanalytical Method Validation. Available at: \u3008http:\/\/www.fda.gov\/\/media\/70858\/download\u3009."},{"key":"10.1016\/j.jpba.2024.116655_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115437","article-title":"Simultaneous determination of 24 antiepileptic drugs and their active metabolites in human plasma by UHPLC-MS\/MS","volume":"232","author":"Jiang","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.jpba.2024.116655_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5090","article-title":"A UPLC-MS\/MS method for simultaneous determination of nine antiepileptic drugs in human plasma and its application in TDM","volume":"35","author":"Qi","year":"2021","journal-title":"Biomed. Chromatogr."},{"issue":"5","key":"10.1016\/j.jpba.2024.116655_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ejhpharm-2022-003589","article-title":"Analytical and clinical validation of an LC-MS\/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots","volume":"31","author":"Besten-Bertholee","year":"2024","journal-title":"Eur. J. Hosp. Pharm."},{"issue":"8","key":"10.1016\/j.jpba.2024.116655_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4253","article-title":"Determination of four antiepileptic drugs in plasma using ultra-performance liquid chromatography with mass detection technique","volume":"32","author":"Hassib","year":"2018","journal-title":"Biomed. Chromatogr."},{"issue":"3","key":"10.1016\/j.jpba.2024.116655_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/FTD.0000000000000600","article-title":"LC-MS\/MS-Based quantification of 9 antiepileptic drugs from a dried sample spot device","volume":"41","author":"D\u02bcUrso","year":"2019","journal-title":"Ther. Drug Monit."},{"issue":"12","key":"10.1016\/j.jpba.2024.116655_bib29","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/bmc.3789","article-title":"Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra-high-performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoring","volume":"30","author":"Dupouey","year":"2016","journal-title":"Biomed. Chromatogr."},{"issue":"7","key":"10.1016\/j.jpba.2024.116655_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3921","article-title":"Simultaneous UPLC-MS\/MS determination of antiepileptic agents for dose adjustment","volume":"31","author":"Farouk","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2024.116655_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.talanta.2013.02.010","article-title":"Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"110","author":"Kuhn","year":"2013","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/j.jpba.2024.116655_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/FTD.0000000000000516","volume":"40","author":"Palte","year":"2018","journal-title":"Ther. Drug Monit."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524006976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:15:31Z","timestamp":1769688931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524006976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":32,"alternative-id":["S0731708524006976"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116655","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an UPLC-MS\/MS method with polarity switching for simultaneous determination of 14 antiepileptic drugs and 2 metabolites in human serum","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116655"}}